Our Pharmaceuticals business is divided into six core areas, Cardiovascular & Metabolism; Immunology; Infectious Diseases & Vaccines; Neuroscience; Oncology; and Pulmonary Hypertension. We seek innovation across all of these areas where there is significant unmet patient need.
CLICK a circle below to see the diseases we are targeting.
Cardivascular and Thrombosis,
Renal DiseaseCardiovascular and Metabolism
Viral Hepatitis & Adjacent Liver Diseases,
Prevention & Treatment of Viral & Bacterial Respiratory Infections,
Adjuvants, Novel Viral Vectors & Vaccine TechnologiesInfectious
Diseases and Vaccines
Neurodegenerative Disorders including Multiple Sclerosis,
Glutamatergic Pathway Diseases,
Solid Tumor Targeted Therapy,
Pulmonary Arterial Hypertension, Idiopathic Pulmonary FibrosisPulmonary Hypertension
Johnson & Johnson Innovation is comprised of a family of complementary teams that bring meaningful solutions and flexible approaches to support collaboration. From incubation facilities to early-stage investing – from venture funding to acquisition, our teams offer partners a full range of capabilities.
Make the Connection
We look forward to our first discussion. If you would like to discuss a collaboration,
please connect with us and we will schedule a call soon.